BOCA RATON, Fla., June 12 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals (Nasdaq: NABI - News) today announced the appointment of Jordan I. Siegel as the company's senior vice president, finance, chief financial officer (CFO) and treasurer, effective June 12, 2006. Mr. Siegel brings to Nabi Biopharmaceuticals nearly 20 years of domestic and international finance, treasury and accounting expertise, as well demonstrated success in leading strategic financial initiatives.
